Rodriguez-Gonzalez, Adán
Hernández, Raquel
Cruz-Castellanos, Patricia
Fernández-Montes, Ana
Castillo-Trujillo, Oscar
Muñoz, María M.
Cano-Cano, Juana M.
Corral, María J.
Esteban, Emilio
Jiménez-Fonseca, Paula
Calderon, Caterina
Funding for this research was provided by:
Spanish Society of Medical Oncology Foundation (FSEOM2018)
Astra Zeneca grant (ES2020-1939, ES2020-1939)
Article History
Received: 7 September 2022
Accepted: 13 February 2023
First Online: 17 February 2023
Declarations
:
: The study was approved by the Research Ethics Committee of the Principality of Asturias (May 17, 2019) and by the Spanish Agency of Medicines and Medical Devices (AEMPS) (identification code: L34LM-MM2GH-Y925U-RJDHQ). The study and all procedures have been performed in accordance with the ethical standards of the National Research Committee and the 1964 Declaration of Helsinki and its subsequent amendments. The study is an observational, non-interventionist trial. Informed consent was obtained from all participants.
: Not applicable.
: The authors declare that they have no competing interest.